Peptides for Bodybuilding (2026)

GH secretagogues stimulate your pituitary gland to release more growth hormone. They do not introduce exogenous GH. Your body produces the hormone; the peptide amplifies the signal.

The primary compounds are MK-677 (oral ghrelin mimetic), CJC-1295 (GHRH analog), and Ipamorelin (selective GHRP). Each activates a different receptor upstream of GH release. CJC-1295 binds the GHRH receptor. Ipamorelin binds the ghrelin receptor. Running both triggers a synergistic GH pulse 3-5 times larger than either compound alone (Ionescu & Bhatt, StatPearls, 2023).

Elevated GH drives two bodybuilding-relevant outcomes: increased IGF-1 production in the liver (which promotes satellite cell differentiation and muscle protein accretion) and enhanced hormone-sensitive lipase activity in adipocytes (which mobilizes stored body fat for oxidation). For a full comparison of fat loss protocols, see sermorelin for fat loss and tesamorelin dosage for fat loss.

Recovery peptides do not build muscle directly. They repair the connective tissue, blood vessels, and muscle fibers damaged by training. The result: you tolerate higher training volume and frequency without accumulating overuse injuries.

BPC-157 is a 15-amino-acid fragment derived from human gastric juice. It promotes angiogenesis (new blood vessel formation) through the VEGFR2 pathway and upregulates growth hormone receptor expression in tendon fibroblasts (Hsieh et al., 2017). TB-500 (Thymosin Beta-4) regulates actin polymerization and recruits stem cells to damaged tissue, addressing systemic repair rather than localized healing (Goldstein et al., Expert Opin Biol Ther, 2012).

For bodybuilders, these compounds address the limiting factor in natural training: connective tissue adaptation lags behind muscle growth by 8-12 weeks. That mismatch causes tendonitis, strains, and forced deloads. Healing peptides close the gap. For detailed injury protocols, see the peptide stacking guide and peptides for joint pain.

Myostatin is a protein your body produces to limit muscle growth. It binds the ActRIIB receptor on muscle cells and suppresses satellite cell proliferation. Follistatin-344 traps myostatin in a high-affinity complex, preventing it from signaling that growth cap.

The proof of concept is dramatic: myostatin-knockout mice develop 2-3 times normal muscle mass. Belgian Blue cattle carry a natural myostatin mutation and display extraordinary musculature. In nonhuman primates, AAV-delivered follistatin increased quadriceps fiber size by 15-36% (Kota et al., Sci Transl Med, 2009).

Follistatin-344 is the most advanced myostatin inhibitor available as a research peptide. It requires strict cycling (10-30 days on, 3-4 weeks off) because the body compensates by upregulating myostatin production during sustained suppression. Full protocols are covered in the follistatin-344 dosage guide.

The 250 mcg dose suits general recovery and tendon maintenance during heavy training blocks. Bump to 500 mcg during peaking phases, competition prep, or when managing an active injury. For a complete breakdown of BPC-157 injection technique, see how to inject BPC-157. Storage protocols are covered in how to store peptides.

The training math explains BPC-157's reputation in bodybuilding. A muscle that heals in 48 hours instead of 72 adds roughly 52 extra productive training sessions per year. Tendons that tolerate higher volume let you progressive overload without forced deloads every 6 weeks.

BPC-157 also upregulates growth hormone receptor expression in tissue fibroblasts. This means your existing GH output produces a stronger local effect at the injury site (Chang et al., 2014). If you stack BPC-157 with a GH secretagogue, the receptor upregulation creates a synergy that neither compound achieves alone.

For more detail on the muscle evidence, see BPC-157 for muscle growth. For women-specific protocols, see BPC-157 benefits for women. For dosage by body weight, see the BPC-157 dosage for 200lb male guide.

TB-500 has a long half-life of approximately 7-10 days. This means precise injection timing matters less than consistency. Split your weekly dose across 2-3 injections during loading (Monday/Wednesday/Friday or Monday/Thursday). During maintenance, a single weekly injection is sufficient.

For exact reconstitution volumes, use the peptide reconstitution calculator. For vial shelf life after mixing, see how long do reconstituted peptides last.

The BPC-157 + TB-500 combination is the most widely used healing stack in bodybuilding, often called the "Wolverine Stack." BPC-157 builds new blood vessels at the injury site. TB-500 sends repair cells along those vessels. Together, they cover both localized and systemic healing.

Protocol: - BPC-157: 250-500 mcg/day (subcutaneous, near injury or abdomen) - TB-500: 5-10 mg/week loading, 2.5-5 mg/week maintenance - Duration: 8-12 weeks - Estimated monthly cost: $80-150

This stack is particularly valuable during high-volume training blocks, competition prep, or when training through a nagging injury. For full stacking protocols, dosage timing, and injection site rotation, see the peptide stacking guide. Check compatibility with other compounds using the Peptide Interaction Checker.

Start at 10 mg for the first two weeks to assess appetite and water retention. Most bodybuilders settle at 25 mg/day. Taking MK-677 before bed exploits the natural nocturnal GH pulse, amplifying the spike rather than creating an off-cycle surge. Fasting for 2 hours before dosing avoids insulin interference with GH release.

Side effects at 25 mg include increased appetite (significant in some users), mild water retention, transient numbness in extremities, and potential increases in fasting blood glucose over extended cycles. Monitor fasting glucose quarterly if running cycles longer than 12 weeks.

MK-677 produces lower peak GH values than injectable combinations like CJC-1295 + Ipamorelin. The injectable pair generates GH pulses 3-5 times above baseline, while MK-677 raises mean 24-hour GH by approximately 40%. The tradeoff: MK-677 maintains elevated GH and IGF-1 around the clock rather than in acute spikes.

For bodybuilders who prioritize simplicity and sustained IGF-1 elevation, MK-677 wins. For those seeking maximum GH pulsatility (important for fat loss and muscle recovery timing), the injectable stack is more effective. Some advanced users combine both: MK-677 as a daily baseline with CJC-1295/Ipamorelin injected pre-workout for acute pulses.

For reconstitution and dosing guidance on injectable alternatives, see the peptide dosage chart.

Mod GRF 1-29 (no DAC) + Ipamorelin (preferred for bodybuilding):

The three-injection protocol (morning/post-workout/bedtime) produces three distinct GH pulses per day. Bedtime injection is the most important: it amplifies the natural nocturnal GH surge. If you can only inject once daily, inject 30 minutes before sleep. For pre-workout timing, inject 15-20 minutes before training to elevate GH during the session.

This stack pairs well with BPC-157 for bodybuilders managing injuries during a GH secretagogue cycle. The growth hormone receptor upregulation from BPC-157 amplifies the tissue-level response to each GH pulse. For stacking details, see the peptide stacking guide.

Realistic expectations based on clinical data and practitioner reports:

These numbers assume consistent training and adequate protein intake (1.6-2.2 g/kg/day). GH secretagogues amplify the results of good training and nutrition. They do not replace them. For fat-specific protocols, compare with sermorelin for fat loss and tesamorelin dosage for fat loss.

Fasting is critical for HGH Fragment efficacy. Insulin blunts the fragment's lipolytic action. Inject on an empty stomach, and avoid eating for 30 minutes post-injection. The two most popular timing protocols are fasted morning injection + pre-bed injection, or fasted morning injection + pre-cardio injection (30 minutes before fasted cardio).

At 500 mcg/day for 12 weeks, a cycle requires approximately 42 mg total. Budget $150-300 depending on source. Use the peptide cost calculator for exact estimates.

Bodybuilders in contest prep often choose HGH Fragment because it strips fat without raising appetite (which MK-677 does) or complicating blood sugar management. Bodybuilders in an off-season bulk prefer MK-677 or CJC-1295 + Ipamorelin because the IGF-1 elevation directly supports new muscle tissue. For additional fat-loss compounds, see how to microdose semaglutide.

FS-344 has a circulating half-life of approximately 90 minutes, requiring daily injection. Post-workout timing aligns the peptide with the natural elevation of protein synthesis after resistance training. At 100 mcg/day for 30 days, one cycle requires 3 mg total. At 200 mcg/day for 20 days, it requires 4 mg. Expect to budget $200-600 per cycle.

Follistatin-344 is a full-length protein, not a short-chain peptide. It requires careful reconstitution (swirl gently, never shake) and must be refrigerated at 2-8 degrees Celsius. For reconstitution steps, use the peptide reconstitution calculator. For complete dosing protocols, see the follistatin-344 dosage guide.

Follistatin 344 carries more risk than the other compounds on this list because myostatin has functions beyond limiting muscle growth. Myostatin regulates cardiac tissue remodeling. Chronic suppression could theoretically affect heart muscle hypertrophy, though the Kota et al. primate study found no cardiac pathology over the study period.

Three rules for follistatin cycling: 1. Never exceed 30 consecutive days of use. The body upregulates myostatin production within 2-4 weeks to compensate. 2. Take 3-4 full weeks off between cycles. This allows myostatin levels to normalize and receptor sensitivity to reset. 3. Monitor bloodwork. Track IGF-1, liver enzymes, and complete blood count before, during, and after each cycle.

For broader safety protocols including bloodwork panels and physician consultation frameworks, see the peptide safety guide.

Goal: Maximize muscle growth, support recovery from high-volume training, elevate GH and IGF-1.

Duration: 12-16 weeks on, 4-8 weeks off. Why this works: CJC-1295 + Ipamorelin elevates GH and IGF-1 for muscle accretion. BPC-157 prevents the tendon and connective tissue injuries that derail heavy training phases. The 250 mcg maintenance dose of BPC-157 is sufficient for injury prevention; increase to 500 mcg if managing an active injury.

Use our Peptide Stack Calculator to build custom protocols with reconstitution volumes and cost estimates.

Goal: Maximize fat loss, preserve lean mass, support recovery on caloric deficit.

Duration: 8-12 weeks. Why this works: HGH Fragment strips fat without raising appetite or blood sugar. BPC-157 and TB-500 prevent the joint and tendon breakdown that accelerates on caloric deficits (reduced recovery resources). This stack avoids MK-677 because its appetite-stimulating effects directly conflict with caloric restriction.

For additional cutting-phase strategies, see tesamorelin dosage for fat loss.

Goal: Heal a specific injury while maintaining as much training volume as possible.

Duration: 6-8 weeks loading, then 4-6 weeks maintenance. Why this works: BPC-157 builds blood vessels at the injury site. TB-500 sends repair cells systemically. Ipamorelin elevates GH, which amplifies tissue remodeling speed. BPC-157 upregulates GH receptor expression in fibroblasts, creating a synergy where each GH pulse from ipamorelin produces a stronger local healing response.

For BPC-157 injection technique near specific injury sites, see how to inject BPC-157. For TB-500 dosing details, use the TB-500 Dosage Calculator.

Blood sugar elevation. GH antagonizes insulin. MK-677 at 25 mg/day raised fasting glucose by approximately 0.3 mmol/L in a 12-month trial of elderly subjects (Murphy et al., 1998). Bodybuilders with insulin resistance, prediabetes, or a family history of type 2 diabetes should monitor fasting glucose and HbA1c every 8-12 weeks during a GH secretagogue cycle.

Water retention. GH increases sodium reabsorption in the kidneys, leading to 1-3 kg of water weight in the first 2-4 weeks. This is cosmetic, not dangerous, but can obscure body composition changes on the scale.

Joint discomfort and carpal tunnel. Sustained GH elevation can cause periarticular fluid retention. Numbness or tingling in the hands indicates the dose may be too high. Reduce by 25-50% if symptoms persist beyond 2 weeks.

Appetite stimulation (MK-677 specifically). MK-677 mimics ghrelin, the hunger hormone. Some users report appetite increases significant enough to derail a cutting diet. This is a feature during bulking and a liability during cutting.

BPC-157 and TB-500 have favorable safety profiles in preclinical research, with no lethal dose established in animal toxicology studies. Community-reported side effects are mild and infrequent.

BPC-157: Occasional reports of headache, dizziness, and nausea. Rare reports of transient blood pressure changes. For a detailed breakdown, see the peptide safety guide.

TB-500: Mild fatigue, headache, and injection-site irritation reported by a minority of users. TB-500 promotes angiogenesis, so anyone with active cancer or a cancer history should not use this compound without physician clearance, as angiogenesis supports tumor vascularization.

Both compounds: Quality control is the primary risk. Peptides from unregulated vendors may contain under-dosed product, bacterial contamination, or misidentified compounds. Source from vendors that provide third-party certificates of analysis (COA) with HPLC purity data. For vendor evaluation, see where to buy peptides in 2026. For regulatory context, see the FDA peptide crackdown 2026.

Follistatin carries the highest theoretical risk profile on this list because myostatin has legitimate physiological functions beyond limiting muscle size.

Cardiac hypertrophy concern. Myostatin regulates cardiac muscle remodeling. Long-term suppression could promote pathological heart enlargement. The Kota et al. primate study found no cardiac issues, but the treatment period was limited. Conservative cycling (10-30 days on, 3-4 weeks off) mitigates this risk.

Reproductive effects. Follistatin binds activin, which plays roles in follicle-stimulating hormone regulation. Prolonged activin suppression could affect reproductive hormone balance. Blood work should include FSH and LH during and after cycles.

No human clinical trial data. All follistatin-344 dosing is extrapolated from animal studies and practitioner observation. The margin of error is wider than for compounds with human trial data.

Baseline and follow-up blood panels should include: complete metabolic panel, IGF-1, GH, testosterone, FSH, LH, liver enzymes, fasting glucose, and HbA1c. For detailed panel recommendations, see the peptide safety guide.